Pharmaceutical Compositions of a Kinase Inhibitor
The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
14.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!